Richardson S, Kgagudi P, Manamela N, Kaldine H, Venter E, Pillay T, et al. Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant. Cell Rep Med. 2023;4:100910 pubmed publisher

Liu L, Iketani S, Guo Y, Reddem E, Casner R, Nair M, et al. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Sci Transl Med. 2022;14:eabn6859 pubmed publisher

Lee A, Jin H, Masudul Haque M, Kim H, Jung H, Park J, et al. Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. Int J Oncol. 2022;60: pubmed publisher

Keeton R, Richardson S, Moyo Gwete T, Hermanus T, Tincho M, Benede N, et al. Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner. Cell Host Microbe. 2021;29:1611-1619.e5 pubmed publisher